Research Article
Analysis of the Distribution and Antibiotic Resistance of Pathogens Causing Infections in Hospitals from 2017 to 2019
Table 20
Analysis of multiple drug resistance rate of ESBLs in 2019.
| | Drugs | Drug resistance rate (%) |
| ESBLs | Ceftriaxone | 96.7 | | Ampicillin-sulbactam | 96.5 | | Ciprofloxacin | 67.2 | | Aztreonam | 64.7 | | Levofloxacin | 61.3 | | Cotrimoxazole | 56.2 | | Ceftazidime | 44.0 | | Gentamicin | 43.1 | | Cefepime | 36.2 | | Tobramycin | 21.5 | | Nitrofurantoin | 14.2 | | Fosfomycin | 13.6 | | Cefoperazone-sulbactam | 8.2 | | Piperacillin-tazobactam | 4.0 | | Ertapenem | 3.0 | | Amikacin | 2.7 | | Imipenem | 1.0 |
|
|